VERONA PHARMA PLC's ticker is VRNA and the CUSIP is 925050106. A total of 105 filers reported holding VERONA PHARMA PLC in Q2 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $47,925,487 | -1.2% | 3,314,349 | +10.0% | 2.24% | +9.6% |
| Q1 2024 | $48,500,875 | -19.1% | 3,014,349 | 0.0% | 2.05% | -36.1% |
| Q4 2023 | $59,925,258 | +22.0% | 3,014,349 | 0.0% | 3.20% | -1.8% |
| Q3 2023 | $49,133,889 | -21.1% | 3,014,349 | +2.4% | 3.26% | -12.2% |
| Q2 2023 | $62,243,538 | +5.3% | 2,944,349 | 0.0% | 3.72% | -13.2% |
| Q1 2023 | $59,122,528 | -19.6% | 2,944,349 | +4.6% | 4.28% | -6.4% |
| Q4 2022 | $73,574,764 | +242.9% | 2,815,720 | +34.1% | 4.57% | +176.9% |
| Q3 2022 | $21,457,000 | – | 2,099,541 | – | 1.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 901,943 | $3,716,000 | 2.47% |
| venBio Partners LLC | 456,770 | $1,882,000 | 1.60% |
| Aisling Capital Management LP | 443,596 | $1,828,000 | 0.80% |
| Vivo Capital, LLC | 1,492,951 | $6,151,000 | 0.56% |
| NEA Management Company, LLC | 1,219,674 | $5,025,000 | 0.26% |
| Novo Holdings A/S | 740,740 | $3,052,000 | 0.20% |
| Orbimed Advisors | 1,250,396 | $5,152,000 | 0.09% |
| Clear Creek Financial Management, LLC | 37,500 | $170,000 | 0.06% |
| Tekla Capital Management LLC | 253,179 | $1,043,000 | 0.05% |
| WEDBUSH SECURITIES INC | 70,950 | $292,000 | 0.04% |